Testing the Addition of the Anti-Cancer Drug Talazoparib to the Combination of Carboplatin and Paclitaxel for the Treatment of Advanced Cancer

NCT02317874 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

NIH

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Talazoparib

Sponsor

National Cancer Institute (NCI)